You are using an older browser version. Please use a supported version for the best MSN experience.

BRAINSTORM CELL THERAPEUTICS INC.

NASDAQ: BCLI
15.09
+0.47
+3.21%

Sector

Healthcare

Industry

Biotechnology & Medical Research

Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Its subsidiary, Brainstorm Cell Therapeutics Ltd. (the Israeli Subsidiary), holds rights to commercialize the technology, NurOwn. NurOwn is in clinical development for the treatment of ALS. The Company has completed over two clinical trials of NurOwn in patients with ALS at Hadassah Medical Center (Hadassah). The first study, a Phase I/II safety and efficacy study of NurOwn in ALS patients administered either intramuscularly or intrathecally. The Company conducted Phase IIa combined (intramuscular and intrathecal) treatment, dose-escalating trial. It had completed treatment of over 10 patients in its ALS Phase IIa NurOwn dose-escalating clinical trial.

Key People

Irit Arbel

Vice Chairman of the Board

Chaim Lebovits

Chief Executive Officer

Ralph Kern

President, Chief Medical Officer

Uri Yablonka

Executive Vice President, Chief Business Officer, Director

June S. Almenoff

Independent Director

  • Brainstorm Cell Therapeutics Inc

  • 1325 Avenue of the Americas Fl 28

  • NEW YORK, NY 10019-6583

  • US.Map

  • Phone: +1 201 4880460

  • Fax: +1 302 6555049

  • brainstorm-cell.com

Incorporated

2006

Employees

32

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 9/8/2020

    • Grant

    • 35,000

    • NA

    • NA

    • 7/24/2020

    • LEBOVITS CHAIM

    • Grant

    • 31,185

    • NA

    • NA

    • 7/16/2020

    • SETBOUN DAVID

    • Bought

    • 5,000

    • 12.95

    • 64,740.00

    • 7/15/2020

    • ABBHI SANKESH

    • Bought

    • 46,779

    • 12.99

    • 607,659.21

    • 7/9/2020

    • ACC INTERNATIONAL HOLDINGS LTD

    • Sold

    • 71,753

    • 13.52

    • 970,373.22

    • 6/23/2020

    • YABLONKA URI

    • Grant

    • 10,000

    • NA

    • NA

    • 6/1/2020

    • LINDBORG STACY R. PH.D.

    • Grant

    • 25,000

    • NA

    • NA

    • 4/7/2020

    • SETBOUN DAVID

    • Grant

    • 50,000

    • NA

    • NA

    • 4/6/2020

    • ABBHI SANKESH

    • Grant

    • 4,657

    • NA

    • NA

    • 3/6/2020

    • KERN RALPH DR.

    • Grant

    • 35,885

    • NA

    • NA

    • 12/24/2019

    • SHAH PREETAM

    • Bought

    • 11,600

    • 3.96

    • 45,929.04

    • 12/24/2019

    • KERN RALPH DR.

    • Bought

    • 3,000

    • 3.88

    • 11,640.00

    • 12/24/2019

    • ARAYA ARTURO

    • Bought

    • 3,000

    • 3.90

    • 11,700.00

    • 12/12/2019

    • POLVERINO ANTHONY J

    • Grant

    • 5,071

    • NA

    • NA

    • 12/12/2019

    • ALMENOFF JUNE SHERIE

    • Grant

    • 2,000

    • NA

    • NA

    • 12/12/2019

    • TAUB MALCOLM S

    • Grant

    • 12,000

    • NA

    • NA

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 9/8/2020

      • Grant

      • 35,000

      • NA

      • NA

      • 7/24/2020

      • LEBOVITS CHAIM

      • Grant

      • 31,185

      • NA

      • NA

      • 7/16/2020

      • SETBOUN DAVID

      • Bought

      • 5,000

      • 12.95

      • 64,740.00

      • 7/15/2020

      • ABBHI SANKESH

      • Bought

      • 46,779

      • 12.99

      • 607,659.21

      • 7/9/2020

      • ACC INTERNATIONAL HOLDINGS LTD

      • Sold

      • 71,753

      • 13.52

      • 970,373.22

      • 6/23/2020

      • YABLONKA URI

      • Grant

      • 10,000

      • NA

      • NA

      • 6/1/2020

      • LINDBORG STACY R. PH.D.

      • Grant

      • 25,000

      • NA

      • NA

      • 4/7/2020

      • SETBOUN DAVID

      • Grant

      • 50,000

      • NA

      • NA

      • 4/6/2020

      • ABBHI SANKESH

      • Grant

      • 4,657

      • NA

      • NA

      • 3/6/2020

      • KERN RALPH DR.

      • Grant

      • 35,885

      • NA

      • NA

      • 12/24/2019

      • SHAH PREETAM

      • Bought

      • 11,600

      • 3.96

      • 45,929.04

      • 12/24/2019

      • KERN RALPH DR.

      • Bought

      • 3,000

      • 3.88

      • 11,640.00

      • 12/24/2019

      • ARAYA ARTURO

      • Bought

      • 3,000

      • 3.90

      • 11,700.00

      • 12/12/2019

      • POLVERINO ANTHONY J

      • Grant

      • 5,071

      • NA

      • NA

      • 12/12/2019

      • ALMENOFF JUNE SHERIE

      • Grant

      • 2,000

      • NA

      • NA

      • 12/12/2019

      • TAUB MALCOLM S

      • Grant

      • 12,000

      • NA

      • NA

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon